Response to single oral dose vitamin D in obese vs non-obese vitamin D deficient children of 5-12 years age

Dr Medha Mittal0 个研究点目标入组 44 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Cases- Obese Indian children (Obesity as defined by BMI more than 27 th adult equivalent
•of Indian Academy of Pediatrics BMI charts) of age group 5 to 12 years presenting to Out-patient clinic
•and pediatric endocrinology clinic at Chacha Nehru Bal Chikitsalaya, Delhi will
•be screened and included in the study if their vitamin D levels are less than 20
•Controls- Apparently healthy children, not overweight or obese, of age group 5-
•12 years presenting to pediatric OPD for minor complaints (like cough, coryza
•for less than 5 days) will be screened for vitamin D deficiency and included in
•the study if their vitamin D levels are less than 20 ng/ml.

•1. Children with confirmed or suspected malabsorption, renal or hepatic
•2. Children who have received vitamin D in therapeutic doses in last 6 months.
•3. Children on psoralen and ultraviolet A therapy (PUVA) for some skin disorder.
•4. Children who have received drugs that may interfere with vitamin D
•metabolism like anticonvulsants, steroids, chemotherapy, antitubercular drugs,
•H2 Blockers, and thiazide diuretics and those on any herbal or ayurvedic
•medications.
•5. Children with any known systemic illness or endocrine or metabolic disorder
•known to be associated with obesity either before or during the course of study
•or subjects with symptoms suggestive of hypothalamic obesity.

发起方

Dr Medha Mittal